Basics Bicara Therapeutics Inc. Common Stock IPO Date: September 13, 2024 Sector: Healthcare Industry: Biotech Market Cap: $931.69M Activated in VL: True Average Daily Range Avg Daily Range: $0.57 | 3.84% Avg Daily Range (30 D): $0.52 | 3.62% Avg Daily Range (90 D): $0.38 | 3.17% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .59M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 76 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 277 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.21M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.37M Avg Closing Volume: 113.7K     News Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A May 22, 2025 @ 9:00 PM Bicara Therapeutics Announces Publication of an Ab... Source: N/A Apr 23, 2025 @ 2:00 PM Bicara Therapeutics to Present Updated Data from O... Source: N/A Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: Globe Newswire Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $4.44 $-.5 $-.68 Diluted EPS $4.44 $-.5 $-.68 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -102.67M $ -27.39M $ -36.85M Operating Income / Loss $ -121.07M $ -32.02M $ -41.79M Cost of Revenue $ $ $ Net Cash Flow $ 285.86M $ M $ M PE Ratio 3.78